https://scholars.lib.ntu.edu.tw/handle/123456789/519162
標題: | Effect of acupressure and trigger points in treating headache: A randomized controlled trial | 作者: | Hsieh L.L.-C. HORNG-HUEI LIOU Lee L.-H. Chen, Tony Hsiu Hsi Yen A.M.-F. |
公開日期: | 2010 | 卷: | 38 | 期: | 1 | 起(迄)頁: | 1-14 | 來源出版物: | American Journal of Chinese Medicine | 摘要: | The efficacy of acupressure in relieving pain has been documented; however, its effectiveness for chronic headache compared to the muscle relaxant medication has not yet been elucidated. To address this, a randomized, controlled clinical trial was conducted in a medical center in Southern Taiwan in 2003. Twenty-eight patients suffering chronic headache were randomly assigned to the acupressure group (n = 14) or the muscle relaxant medication group (n = 14). Outcome measures regarding self-appraised pain scores (measured on a visual analogue scale; VAS) and ratings of how headaches affected life quality were recorded at baseline, 1 month after treatment, and at a 6-month follow-up. Pain areas were recorded in order to establish trigger points. Results showed that mean scores on the VAS at post-treatment assessment were significantly lower in the acupressure group (32.9±26.0) than in the muscle relaxant medication group (55.7±28.7) (p = 0.047). The superiority of acupressure over muscle relaxant medication remained at 6-month follow-up assessments (p = 0.002). The quality of life ratings related to headache showed similar differences between the two groups in the post treatment and at six-month assessments. Trigger points BL2, GV20, GB20, TH21, and GB5 were used most commonly for etiological assessment. In conclusion, our study suggests that 1 month of acupressure treatment is more effective in reducing chronic headache than 1 month of muscle relaxant treatment, and that the effect remains 6 months after treatment. Trigger points help demonstrate the treatment technique recommended if a larger-scale study is conducted in the future. ? 2010 World Scientific Publishing Company & Institute for Advanced Research in Asian Science and Medicine. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951215972&doi=10.1142%2fS0192415X10007634&partnerID=40&md5=eed6d294cd234adcee71672163796e04 https://scholars.lib.ntu.edu.tw/handle/123456789/519162 |
DOI: | 10.1142/S0192415X10007634 | SDG/關鍵字: | mephenoxalone; riboflavin; mephenoxalone; muscle relaxant agent; oxazole derivative; acupressure; adult; aged; analgesia; article; chronic disease; clinical article; clinical trial; controlled clinical trial; controlled study; female; follow up; headache; human; male; pain assessment; quality of life; randomized controlled trial; Taiwan; trigger point; visual analog scale; acupuncture; comparative study; headache and facial pain; middle aged; muscle relaxation; pain; relaxation training; treatment outcome; Acupressure; Acupuncture Points; Adult; Aged; Aged, 80 and over; Female; Headache Disorders; Humans; Male; Middle Aged; Muscle Relaxation; Neuromuscular Agents; Oxazoles; Pain; Pain Measurement; Quality of Life; Relaxation Therapy; Taiwan; Treatment Outcome; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。